The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

One of the most amazing things to happen in biology in the last couple of years is cellular reprogramming. We learned how to convert one type of cell into another. In 2006, Shinya Yamanaka made a ...

A new technique developed at the Massachusetts Institute of Technology helps convert skin cells into neurons without needing to transform them first into stem cells. As demonstrated in mouse cells, ...

About 20 years ago, scientists discovered that skin cells could be converted into pluripotent stem cells (iPSCs), which can ...

Scientists have developed a breakthrough technique to directly convert skin cells into neurons, bypassing the need for stem ...

GERMANTOWN, MARYLAND / ACCESS Newswire / March 4, 2025 / uBriGene Biosciences (uBriGene), a leading cell and gene therapy CDMO, is pleased to announce the submission of its Drug Master File (DMF ...

Want to share this FREE webinar with a colleague? Fill out the form below and we'll send your colleague an invitation to the "Development of iPSCs: From Reprogramming to Functional Assessment" event.

MIT researchers devised a process to convert a skin cell directly into a neuron, eliminating the need to generate induced pluripotent stem cells. Such neurons could be used to treat spinal cord ...

When Shinya Yamanaka discovered that he could reprogram somatic cells into pluripotent stem cells in 2006, he seemingly set the stage for a new era in disease modelling and drug discovery.

Rapid progress with induced pluripotent stem cells is bringing scientists closer to understanding their strengths and weaknesses as embryonic stem cell stand-ins. You have full access to this ...

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S ...

Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ACCESS Newswire / March 4, 2025 / uBriGene Biosciences (uBriGene), a leading cell ...